DL-dimyristoylphosphatidylglycerol

DB11284ApprovedSmall molecule

DL-dimyristoylphosphatidylglycerol is a phospholipid used in commercially available pharmaceutical preparations to solubilize drugs for injection.

Mechanism: As a phospholipid, DL-dimyristoylphosphatidylglycerol can form a micelle with a hydrophobic core to contain lipophilic drugs while maintaining a hyrophilic outer portion to allow increased solubility of the drug in the aqueous environment of the blood or gastrointestinal tract.
Curator reviewed · 1 reference
Primary indication: DL-dimyristoylphosphatidylglycerol is not an considered an active pharmacological ingredient in pharmaceutical preparations and so has no official indications.Curator reviewed
Formula / weight: C₃₄H₆₇O₁₀P · 666.874 g/mol (avg)
First approval: United States, 2010
Also known as: Dimyristoylphosphatidylglycerol · DMPG
Brand names: Abelcet

Resolves to

Compound

Clinical / RWD

Structure

InChIKeyBPHQZTVXXXJVHI-UHFFFAOYSA-NSMILESCCCCCCCCCCCCCC(=O)OCC(COP(O)(=O)OCC(O)CO)OC(=O)CCCCCCCCCCCCC

Targets

What you can answer from here — as of July 09, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Marketed productAcross 1 country and 1 labeller

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with DL-dimyristoylphosphatidylglycerol, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.